Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/09/2012CA2826662A1 Treatment of bacterial infections
08/09/2012CA2826644A1 Compositions and methods for treatment of glaucoma
08/09/2012CA2826602A1 Methods for treating brain injury
08/09/2012CA2826515A1 (5s,8s)-3-(4'-chlor-3'-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one (compound a) for treatment
08/09/2012CA2826513A1 Pharmaceutical preparation
08/09/2012CA2826506A1 Compositions and methods for treating chronic inflammation and inflammatory diseases
08/09/2012CA2826452A1 Compositions and methods for treating cardiovascular diseases
08/09/2012CA2826391A1 Pharmaceutical formulations including an amine compound
08/09/2012CA2826356A1 Substance for preventing and improving arthritis
08/09/2012CA2826295A1 Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
08/09/2012CA2826262A1 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
08/09/2012CA2826260A1 Methods of making hiv attachment inhibitor prodrug compound and intermediates
08/09/2012CA2826257A1 C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors
08/09/2012CA2826232A1 Method of enhancing hair growth
08/09/2012CA2826217A1 Transdermal patch
08/09/2012CA2826193A1 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament, and method for the production thereof
08/09/2012CA2826180A1 Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
08/09/2012CA2826178A1 A compound separated from monascus-fermented rice, the preparation method and uses thereof
08/09/2012CA2826174A1 Novel macrolide derivative
08/09/2012CA2826166A1 Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
08/09/2012CA2826113A1 C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
08/09/2012CA2826073A1 Skin renewal enhancer
08/09/2012CA2826051A1 7-azaindole derivatives
08/09/2012CA2826003A1 Patch preparation
08/09/2012CA2825926A1 Cellulose-based nanoparticles for drug delivery
08/09/2012CA2825860A1 Carotenoid particles and uses thereof
08/09/2012CA2825801A1 Production method for adhesive patch
08/09/2012CA2825798A1 Patch preparation
08/09/2012CA2825786A1 Externally-used drug for treating skin disorder and method for producing same
08/09/2012CA2825700A1 Alpha-ketoheterocycles and methods of making and using
08/09/2012CA2825690A1 Pharmaceutical formulation
08/09/2012CA2825682A1 Spiro aminic compounds with nk1 antagonist activity
08/09/2012CA2825605A1 Novel heterocyclic derivatives
08/09/2012CA2825599A1 Hdac inhibitors and therapeutic methods using the same
08/09/2012CA2825456A1 Treatment for lipodystrophy
08/09/2012CA2825399A1 Implantable device for controlled release of low solubility drug
08/09/2012CA2825279A1 New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
08/09/2012CA2825204A1 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/09/2012CA2825165A1 Therapeutic or prophylactic agent for cachexia
08/09/2012CA2825162A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
08/09/2012CA2825152A1 Pharmaceutical compositions of cytidine analogs and methods of use thereof
08/09/2012CA2825059A1 Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)
08/09/2012CA2824929A1 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
08/09/2012CA2824835A1 Pharmaceutical composition comprising opioid agonist and sequestered antagonist
08/09/2012CA2824750A1 Analgesic
08/09/2012CA2824735A1 Prophylactic or therapeutic agent for a peripheral nerve disorder induced by anti-cancer agents
08/09/2012CA2824432A1 Aerosol pirfenidone and pyridone analog compounds and uses thereof
08/09/2012CA2824092A1 Methods of using alk inhibitors
08/09/2012CA2823994A1 Combinations comprising macitentan for the treatment of glioblastoma multiforme
08/09/2012CA2823870A1 Inhibitors of the interaction of the sigma-1 receptor with herg for use in the treatment of cancer
08/09/2012CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors
08/09/2012CA2817462A1 Method of preparation of metaxalone
08/09/2012CA2810515A1 Hydrated n-fullerene amino acids, method for producing the latter, and pharmaceutical compositions on the basis thereof
08/09/2012CA2810507A1 Homo- and hetero-polyamino-acid derivatives of fullerene c60, method for producing same, and pharmaceutical compositions based on said derivatives
08/08/2012EP2484688A1 Peptide epoxyketones for proteasome inhibition
08/08/2012EP2484681A1 Chemically and chirally pure gentisate salt of solifenacin
08/08/2012EP2484680A1 Useful Combinations of Monobactam Antibiotics with beta-Lac-tamase Inhibitors
08/08/2012EP2484679A2 N3-heteroaryl substituted triazoles and n5-heteroaryl substitued triazoles useful as axl inhibitors
08/08/2012EP2484678A1 4-(substituted anilino)quinazoline derivatives as tyrosine kinase inhibitors
08/08/2012EP2484675A1 Novel phenylpyridine derivative and medicinal agent comprising same
08/08/2012EP2484674A1 Spiro aminic compounds with NK1 antagonist activity
08/08/2012EP2484670A1 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
08/08/2012EP2484669A1 Novel phenol derivative
08/08/2012EP2484668A1 Indazole analogue
08/08/2012EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
08/08/2012EP2484661A1 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same
08/08/2012EP2484385A1 Composition for treatment of pancreatic cancer
08/08/2012EP2484382A1 Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
08/08/2012EP2484381A1 Composition for a treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/08/2012EP2484370A1 Composition having lipolysis-promoting effect
08/08/2012EP2484367A1 Agent for preventing adverse side effects of carcinostatic agent
08/08/2012EP2484366A1 Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events
08/08/2012EP2484365A1 Compositions and method for treatment of neovascular diseases
08/08/2012EP2484364A1 Compositionas and methods for treatment of neovascular diseases
08/08/2012EP2484363A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-5-methylthiophene-2-carboxamide
08/08/2012EP2484362A2 Use of gymnodimine, analogues and derviatives for the treatment and/or prevention of neurodegenerative diseases associated with tau and b-amyloid
08/08/2012EP2484361A1 Agent for reducing visceral fat weight
08/08/2012EP2484360A1 Phenylboronic acid compounds as antiviral agents
08/08/2012EP2484359A1 Heparanase activity inhibitor
08/08/2012EP2484358A1 Agent for inhibiting decrease of visceral fat in patient with parkinson's disease
08/08/2012EP2484357A1 Oral composition for reducing skin roughness
08/08/2012EP2484356A1 Oral composition for reducing wrinkle formation
08/08/2012EP2484355A1 Laminin-332 production stimulating composition
08/08/2012EP2484354A1 Antioxidant composition
08/08/2012EP2484353A1 Oral composition for alleviation of ultraviolet radiation-induced damage
08/08/2012EP2484352A1 Liquid compositions of calcium acetate
08/08/2012EP2484351A1 Use of steroid sulfatase inhibitors for the treatment of preterm labor
08/08/2012EP2484350A1 Pharmaceutical preparation containing a complex of a salt of propofol and a cyclodextrin
08/08/2012EP2484349A1 Heparanase-activity inhibitor, wrinkle ameliorating agent containing same, and pharmaceutical composition
08/08/2012EP2484348A2 Pharmaceutical composition for treating and preventing diseases involving joints and connective tissue
08/08/2012EP2484347A1 Transdermal delivery systems comprising bupivacaine
08/08/2012EP2484341A1 Melanin production inhibitor
08/08/2012EP2484340A1 Collagen production accelerating composition
08/08/2012EP2483685A1 Method of calculating a phosphorus-protein ratio
08/08/2012EP2483407A2 Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
08/08/2012EP2483405A1 Modulation of phospholipase d for the treatment of the acute and chronic effects of ethanol
08/08/2012EP2483332A1 Crosslinked hydrogels and related method of preparation
08/08/2012EP2483290A1 Cyclic peptide inhibitors of hepatitis c virus replication
08/08/2012EP2483288A2 Phosphoramidate derivatives of nucleosides
08/08/2012EP2483286A1 Method for the preparation of a crystalline form of 1-chloro-4- (beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene
1 ... 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 ... 7860